Related Experiment Video

Updated: Aug 9, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Pneumocystis jirovecii genotypes and granulomatous pneumocystosis

A Totet1, H Duwat, G Daste

  • 1Service de Parasitologie et Mycologie Médicale, Centre Hospitalier Universitaire, Hôpital sud, 1, avenue René-Laennec, 80054 Amiens, France.

Medecine Et Maladies Infectieuses
|April 4, 2006
PubMed

Insights

Molecular typing of Pneumocystis jirovecii revealed three types in a patient with granulomatous Pneumocystis pneumonia (PCP). These findings suggest host factors, not the microorganism, drive the granulomatous response in PCP.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Pneumocystis pneumonia (PCP) is an opportunistic infection.
  • PCP typically presents as diffuse alveolar pneumonia.
  • Granulomatous PCP is a less common presentation.

Observation:

  • This study performed molecular typing of Pneumocystis jirovecii in a patient with granulomatous PCP.
  • Three distinct types of P. jirovecii (B(1)a(3), B(1)a(4), B(1)b(2)) were identified.
  • These types were previously reported in patients with diffuse alveolar PCP.

Findings:

  • Identical P. jirovecii strains can cause both granulomatous and diffuse alveolar PCP.
  • The identified P. jirovecii types were B(1)a(3), B(1)a(4), and B(1)b(2).

Implications:

  • The pathogenesis of granulomatous PCP may be influenced by host immune response factors.
  • This suggests host factors play a crucial role in the development of granulomatous inflammation in PCP.
  • Further research into host-pathogen interactions in PCP is warranted.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: